Hypersplenism Caused by Portal Hypertension due to Abnormal Liver Function
top of page
Asian Institute of Research, Journal Publication, Journal Academics, Education Journal, Asian Institute
Asian Institute of Research, Journal Publication, Journal Academics, Education Journal, Asian Institute

Journal of Health and Medical Sciences

ISSN 2622-7258

Screen Shot 2018-08-12 at 1.24.09 AM.png
Screen Shot 2018-08-12 at 1.24.02 AM.png
Screen Shot 2018-08-12 at 1.23.57 AM.png
Screen Shot 2018-08-12 at 1.23.52 AM.png
crossref
doi
open access

Published: 12 April 2024

Hypersplenism Caused by Portal Hypertension due to Abnormal Liver Function

Ahmad Mahmood, Mohammad Shoaib, Mustafa Zhayier, Rexiati Ruze, Tiemin Jiang

Xinjiang Medical University, China

journal of social and political sciences
pdf download

Download Full-Text Pdf

doi

10.31014/aior.1994.07.02.313

Pages: 1-9

Keywords: Hypersplenism, Hypertension, Liver

Abstract

Portal hypertension refers to a range of complications that arise from elevated pressure in the portal vein system, which can be caused by various factors. The primary causes of portal hypertension are cirrhosis induced by viral hepatitis and non-cirrhotic factors such as Budd-Chiari syndrome, portal cavernous transformation, and regional portal hypertension. Patients with portal hypertension experience increased blood flow and resistance in the portal vein, leading to enlargement of the spleen and increased splenic function. This, in turn, can result in a decrease in blood cells and an overgrowth of bone marrow hematopoietic cells, leading to complications like anemia, bleeding, and infection. The treatment for splenomegaly induced by portal hypertension involves both medical and surgical approaches, with surgical treatment being the primary method. This article provides an overview of the common treatment options for splenomegaly caused by portal hypertension.

References

  1. Ahuja, C., Farsad, K., & Chadha, M. (2015). An Overview of Splenic Embolization. AJR Am J Roentgenol, 205(4), 720-725. doi:10.2214/ajr.15.14637

  2. Akita, H., & Sakoda, K. (1980). Portopulmonary shunt by splenopneumopexy as a surgical treatment of Budd-Chiari syndrome. Surgery, 87(1), 85-94.

  3. Al-raimi, K., & Zheng, S. S. (2016). Postoperative outcomes after open splenectomy versus laparoscopic splenectomy in cirrhotic patients: a meta-analysis. Hepatobiliary Pancreat Dis Int, 15(1), 14-20. doi:10.1016/s1499-3872(16)60053-x

  4. Assal, F., El Kassas, M., Esmail, E., Elbadry, A. A., Abousaif, S., Mahdy, R., & Elfert, A. (2017). Microwave ablation in the spleen versus partial splenic artery embolisation: A new technique for hypersplenism in cirrhosis. Arab J Gastroenterol, 18(1), 25-29. doi:10.1016/j.ajg.2017.01.001

  5. Beermann, M., Delle, M., Magnusson, M., & Casswall, T. (2021). [Microwave ablation of the spleen: An easy and gentle method for treatment of secondary splenomegaly in children. A case report]. Lakartidningen, 118.

  6. Bell-Allen, N., McNamara, A., Bull, N., Lewin, J., & O'Rourke, N. (2024). Laparoscopic partial splenectomy in distal pancreatectomy may preserve splenic function. ANZ J Surg. doi:10.1111/ans.18880

  7. Bolognesi, M., Merkel, C., Sacerdoti, D., Nava, V., & Gatta, A. (2002). Role of spleen enlargement in cirrhosis with portal hypertension. Dig Liver Dis, 34(2), 144-150. doi:10.1016/s1590-8658(02)80246-8

  8. Buob, S., Johnston, A. N., & Webster, C. R. (2011). Portal hypertension: pathophysiology, diagnosis, and treatment. J Vet Intern Med, 25(2), 169-186. doi:10.1111/j.1939-1676.2011.00691.x

  9. Cai, M., Huang, W., Lin, C., Li, Z., Qian, J., Huang, M., . . . Zhu, K. (2016). Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications. Eur Radiol, 26(2), 370-380. doi:10.1007/s00330-015-3839-4

  10. Chaouch, M. A., Hadj Taieb, A., Ben Jabra, S., Noomen, M., Zayeti, M., Mili, E., . . . Noomen, F. (2024). A case report of a large Splenic epidermoid cyst treated with partial splenectomy. Ann Med Surg (Lond), 86(2), 1220-1223. doi:10.1097/ms9.0000000000001675

  11. Cianci, P., Tartaglia, N., Altamura, A., Fersini, A., Vovola, F., Sanguedolce, F., . . . Neri, V. (2016). A recurrent epidermoid cyst of the spleen: report of a case and literature review. World J Surg Oncol, 14, 98. doi:10.1186/s12957-016-0857-x

  12. Dhiman, R. K., Chawla, Y., Vasishta, R. K., Kakkar, N., Dilawari, J. B., Trehan, M. S., . . . Suri, S. (2002). Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol, 17(1), 6-16. doi:10.1046/j.1440-1746.2002.02596.x

  13. Iwakiri, Y. (2014). Pathophysiology of portal hypertension. Clin Liver Dis, 18(2), 281-291. doi:10.1016/j.cld.2013.12.001

  14. Li, L., Duan, M., Chen, W., Jiang, A., Li, X., Yang, J., & Li, Z. (2017). The spleen in liver cirrhosis: revisiting an old enemy with novel targets. J Transl Med, 15(1), 111. doi:10.1186/s12967-017-1214-8

  15. Liu, P., Zhu, S. S., Cao, X. G., Kongkam, P., Ullah, S., & Guo, C. Q. (2024). Endoscopic ultrasound-guided partial splenic embolization for hypersplenism: a novel alternative. Endoscopy, 56(S 01), E144-e145. doi:10.1055/a-2244-4009

  16. Martins, G. L., Bernardes, J. P., Rovella, M. S., Andrade, R. G., Viana, P. C., Herman, P., . . . Menezes, M. R. (2015). Radiofrequency ablation for treatment of hypersplenism: A feasible therapeutic option. World J Gastroenterol, 21(20), 6391-6397. doi:10.3748/wjg.v21.i20.6391

  17. Merchant, T. S., & Kotawala, H. (2024). Totally laparoscopic partial splenectomy and gastropexy for a splenic cyst in a wandering spleen. J Minim Access Surg. doi:10.4103/jmas.jmas_212_23

  18. Merkel, C., Gatta, A., Arnaboldi, L., & Zuin, R. (1985). Splenic haemodynamics and portal hypertension in patients with liver cirrhosis and spleen enlargement. Clin Physiol, 5(6), 531-539. doi:10.1111/j.1475-097x.1985.tb00766.x

  19. Metwally, K., Essam, T., Atwa, A., Awad, S., & Abdelsameea, E. (2022). Helicobacter pylori versus platelet-to-spleen ratio as a risk factor for variceal bleeding in patients with liver-cirrhosis-related portal hypertension. Am J Med Sci, 364(1), 23-28. doi:10.1016/j.amjms.2021.10.018

  20. Miko, I., Nemeth, N., Peto, K., Furka, A., Toth, L., & Furka, I. (2017). Changes of red blood cell aggregation parameters in a long-term follow-up of splenectomy, spleen-autotransplantation and partial or subtotal spleen resections in a canine model. Clin Hemorheol Microcirc, 67(1), 91-100. doi:10.3233/ch-170264

  21. Morgan, T. L., & Tomich, E. B. (2012). Overwhelming post-splenectomy infection (OPSI): a case report and review of the literature. J Emerg Med, 43(4), 758-763. doi:10.1016/j.jemermed.2011.10.029

  22. Ozturk, O., Eldem, G., Peynircioglu, B., Kav, T., Görmez, A., Cil, B. E., . . . Bayraktar, Y. (2016). Outcomes of partial splenic embolization in patients with massive splenomegaly due to idiopathic portal hypertension. World J Gastroenterol, 22(43), 9623-9630. doi:10.3748/wjg.v22.i43.9623

  23. Pozzato, C., Marzano, L., Botta, A., Anania, R. M., & Uslenghi, C. M. (1998). [Splenomegaly and hypersplenism in cirrhotic patients before and after orthotopic liver transplantation]. Radiol Med, 95(4), 349-352.

  24. Putnik, S. S., & Ilic, M. D. (2023). Usability of radiofrequency single ablation electrode in spleen surgery. Cir Esp (Engl Ed). doi:10.1016/j.cireng.2023.11.012

  25. Rajekar, H., Vasishta, R. K., Chawla, Y. K., & Dhiman, R. K. (2011). Noncirrhotic portal hypertension. J Clin Exp Hepatol, 1(2), 94-108. doi:10.1016/s0973-6883(11)60128-x

  26. Rehman, Z. U., & Nazir, Z. (2019). Distal Splenorenal Shunt (DSRS) in Children with Extrahepatic Portal Hypertension. J Coll Physicians Surg Pak, 29(12), 1228-1229. doi:10.29271/jcpsp.2019.12.1228

  27. Sarin, S. K., & Kumar, A. (2006). Noncirrhotic portal hypertension. Clin Liver Dis, 10(3), 627-651, x. doi:10.1016/j.cld.2006.08.021

  28. Sarin, S. K., Kumar, A., Chawla, Y. K., Baijal, S. S., Dhiman, R. K., Jafri, W., . . . Sollano, J. (2007). Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int, 1(3), 398-413. doi:10.1007/s12072-007-9010-9

  29. Schouten, J. N., Garcia-Pagan, J. C., Valla, D. C., & Janssen, H. L. (2011). Idiopathic noncirrhotic portal hypertension. Hepatology, 54(3), 1071-1081. doi:10.1002/hep.24422

  30. Schouten, J. N., Verheij, J., & Seijo, S. (2015). Idiopathic non-cirrhotic portal hypertension: a review. Orphanet J Rare Dis, 10, 67. doi:10.1186/s13023-015-0288-8

  31. Simonetto, D. A., Liu, M., & Kamath, P. S. (2019). Portal Hypertension and Related Complications: Diagnosis and Management. Mayo Clin Proc, 94(4), 714-726. doi:10.1016/j.mayocp.2018.12.020

  32. Sinwar, P. D. (2014). Overwhelming post splenectomy infection syndrome - review study. Int J Surg, 12(12), 1314-1316. doi:10.1016/j.ijsu.2014.11.005

  33. Talwar, A., Gabr, A., Riaz, A., Desai, K., Thornburg, B., Mouli, S., . . . Salem, R. (2020). Adverse Events Related to Partial Splenic Embolization for the Treatment of Hypersplenism: A Systematic Review. J Vasc Interv Radiol, 31(7), 1118-1131.e1116. doi:10.1016/j.jvir.2019.08.015

  34. Ueda, J., Mamada, Y., Taniai, N., Yoshioka, M., Matsushita, A., Mizutani, S., . . . Yoshida, H. (2023). Distribution of splenic arterial flow and segmental spleen volume for partial splenic arterial embolization. J Nippon Med Sch. doi:10.1272/jnms.JNMS.2024_91-108

  35. Vadlapudi, S. S., Srivastava, A., Saini, N., Sen Sarma, M., Poddar, U., & Yachha, S. K. (2024). Aetiology and diagnostic utility of serum ascites albumin gradient in children with ascites. Dig Liver Dis. doi:10.1016/j.dld.2024.02.004

  36. Yoshida, H., Shimizu, T., Yoshioka, M., Matsushita, A., Kawano, Y., Ueda, J., . . . Mamada, Y. (2023). The Role of the Spleen in Portal Hypertension. J Nippon Med Sch, 90(1), 20-25. doi:10.1272/jnms.JNMS.2023_90-104

  37. Yu, Q., Rao, A., Fergus, J., Lorenz, J., & Zangan, S. (2024). Endovascular Retrieval of a Damaged Transjugular Intrahepatic Portosystemic Shunt Stent Graft. J Vasc Interv Radiol. doi:10.1016/j.jvir.2024.02.018

  38. Zhang, X., Tang, S., Huang, G., Xu, Z., Feng, C., Yan, G., & He, S. (2022). Minimally invasive treatment of cirrhotic secondary hypersplenism with high-intensity focused ultrasound. Sci Rep, 12(1), 20700. doi:10.1038/s41598-022-24416-x

  39. Zhang, Y., Zhang, S., Chen, Q., Cai, D., Luo, W., Jin, Y., & Gao, Z. (2024). Robotic-Assisted and Laparoscopic Splenectomy in Children: A Single Center Comparative Study. J Laparoendosc Adv Surg Tech A. doi:10.1089/lap.2023.0221

  40. Zhu, J., Zhu, H., Mei, Z., Zhang, L., Jin, C., Ran, L., . . . Yang, W. (2014). High-intensity focused ultrasound ablation: an effective and safe treatment for secondary hypersplenism. Br J Radiol, 87(1043), 20140374. doi:10.1259/bjr.20140374

  41. Zouki, J., & Fry, D. (2024). Partial Splenectomy and Splenic Wrapping for a High-Grade Splenic Injury: A Case Report. Cureus, 16(2), e54372. doi:10.7759/cureus.54372

bottom of page